; (9) promotion of regulatory compatibility and cooperation to facilitate trade and investment related to medical goods and accelerate manufacturing of such goods during a public health emergency; and (10) exemption of parties to the agreement from trade-restrictive measures imposed with respect to medical goods during a public health emergency. (d) Report required Not later than 180 days after the date of the enactment of this Act, and every 180 days thereafter, the President shall submit to Congress a report on the status of negotiations conducted under subsection (a) for trusted trade partner agreements. 6. Congressional oversight, notice, consultations, access to information, and review (a) Notice Not later than 60 days before initiating negotiations with a trusted trade partner under section 5(a) for a trusted trade partner agreement, the President shall submit to Congress written notice of the intention of the President to enter into the negotiations, which shall include the date negotiations will begin and the trusted trade partner with whom the President seeks to enter into the agreement. (b) Consultation with members of Congress (1) Consultation during negotiations and access to information In the course of negotiations under section 5(a) for a trusted trade partner agreement, the Trade Representative shall— (A) meet upon request with the appropriate committees of Congress regarding negotiating objectives, the status of negotiations in progress, and potential effects to the laws of the United States with respect to the agreement; (B) upon request by the appropriate committees of Congress, provide access to pertinent documents relating to the negotiations; and (C) consult closely and on a timely basis with, and keep fully apprised of the negotiations, the appropriate committees of Congress. (2) Consultation before entry into agreement Before entering into a trusted trade partner agreement under section 5, the Trade Representative shall consult with— (A) the appropriate committees of Congress